Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 2, Pages 341-352
Publisher
Springer Nature
Online
2013-12-04
DOI
10.1038/bjc.2013.752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of Gambogic Acid-Induced Apoptosis in Non-Small Cell Lung Cancer Cells in Relation to Transferrin Receptors
- (2014) Xiaoli Zhu et al. JOURNAL OF CHEMOTHERAPY
- Gambogic Acid as a Non-Competitive Inhibitor of ATP-Binding Cassette Transporter B1 Reverses the Multidrug Resistance of Human Epithelial Cancers by Promoting ATP-Binding Cassette Transporter B1 Protein Degradation
- (2013) Xu Wang et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Viability inhibition effect of gambogic acid combined with cisplatin on osteosarcoma cells via mitochondria-independent apoptotic pathway
- (2013) Wei Zhao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Smad7 sensitizes A549 lung cancer cells to cisplatin-induced apoptosis through heme oxygenase-1 inhibition
- (2012) Woo-Kwang Jeon et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells
- (2012) Chenglin Li et al. Biochemistry and Cell Biology
- Heme Oxygenase-1 in Lung Disease
- (2012) Chintan M. Raval et al. CURRENT DRUG TARGETS
- Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data
- (2012) María S. Degese et al. LUNG CANCER
- Caspase Substrates and Cellular Remodeling
- (2011) Emily D. Crawford et al. Annual Review of Biochemistry
- GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1
- (2011) Lin Zheng et al. CANCER LETTERS
- Are there new therapeutic options for treating lung cancer based on herbal medicines and their metabolites?
- (2011) Soo-Jin Jeong et al. JOURNAL OF ETHNOPHARMACOLOGY
- Selective killing of cancer cells by a small molecule targeting the stress response to ROS
- (2011) Lakshmi Raj et al. NATURE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Herbal therapy use by cancer patients: A literature review on case reports
- (2010) Oluwadamilola Olaku et al. EUROPEAN JOURNAL OF CANCER
- NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target
- (2010) Wenshu Chen Frontiers in Bioscience-Landmark
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
- (2010) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review
- (2009) Sisi Chen et al. LUNG CANCER
- Reactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cells
- (2009) Feifei Nie et al. TOXICOLOGY
- Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin
- (2007) Hak-Ryul Kim et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More